Without screening, detecting tumours at a treatable stage is extremely difficult
A 54-year-old Cambodian woman with no symptoms and no smoking history chose to add a low-dose CT scan to a routine checkup — a small decision that would save her life. The scan found a nodule; a follow-up found it had doubled; a biopsy found cancer; and surgery, guided by robotic precision, found a cure. Her story sits at the intersection of medical technology and human fortune, a reminder that the diseases most likely to kill us are often the ones we cannot yet feel.
- A seven-millimetre nodule — silent, symptomless, and growing — was the only sign that a healthy non-smoking woman was carrying lung cancer.
- When the nodule doubled in three months, her daughter's alarm drove the family across the border to seek answers at a specialist hospital in Ho Chi Minh City.
- A multidisciplinary tumour board moved swiftly, recommending robot-assisted surgery that removed the cancerous lobe and surrounding lymph nodes in roughly two hours.
- One day after the operation she was walking; three days later she went home — no chemotherapy, no radiation, no prolonged treatment of any kind.
- Her case sharpens a stark statistical argument: a stage IA diagnosis carries a 95% five-year survival rate, while stage IV falls below 15%, separated only by how early the disease is found.
A 54-year-old Cambodian woman arrived at a routine health screening with no symptoms and no smoking history — nothing to suggest danger. On a quiet instinct, she added a low-dose CT scan of her lungs to the standard tests. It found a seven-millimetre nodule. Doctors recommended watching it and scheduled a follow-up three months later.
At that follow-up, the nodule had doubled to fourteen millimetres. Her daughter, alarmed by the rapid growth, sought a second opinion across the border at FV Hospital in Ho Chi Minh City. A needle biopsy — performed without opening the chest — returned a definitive result: non-small cell lung cancer. Dr. Luong Ngoc Trung, a robotic thoracic surgeon at the hospital, noted that without screening, the tumour would have remained invisible until it announced itself through cough, weight loss, or worse.
The hospital's tumour board unanimously recommended robot-assisted surgery using the da Vinci Xi system. On June 2, Dr. Trung and his team removed the affected lobe and surrounding lymph nodes in roughly two hours, the robotic system's magnified 3D vision allowing precise work in the confined space of the chest with minimal damage to healthy tissue.
Recovery was swift. She was walking the day after surgery and went home after three nights. Final pathology confirmed stage IA disease — the earliest meaningful stage — with complete removal of the tumour. No chemotherapy. No radiation. Her daughter described the family's relief: one surgery, and her mother returned to normal life.
Dr. Trung laid out what the numbers mean: stage IA carries a 95% five-year survival rate; stage IV falls below 15%. Most lung cancers today are caught only after symptoms appear, by which point the window for surgery narrows and treatment grows longer and costlier. Low-dose CT uses a fraction of conventional radiation yet can detect nodules just millimetres across — far beyond what a chest X-ray can see. Many countries now recommend it for people over 50, smokers and non-smokers alike. This woman's quiet decision to add one more test to a routine checkup is a plain argument for why.
A 54-year-old Cambodian woman walked into a routine health screening with no symptoms, no smoking history, and no reason to suspect anything was wrong. During that checkup, she chose to add a low-dose CT scan of her lungs to the battery of tests. The scan found a nodule measuring seven millimetres—small enough that doctors recommended simply watching it, scheduling a follow-up three months out.
When she returned for that follow-up, the nodule had doubled in size. Fourteen millimetres now. The rapid growth alarmed her daughter enough to seek a second opinion across the border in Ho Chi Minh City, at FV Hospital. There, doctors performed a needle biopsy without opening her chest, threading a thin instrument through the skin to extract tissue. The pathology came back definitive: non-small cell lung cancer.
Dr. Luong Ngoc Trung, a robotic thoracic surgeon at FV Hospital, saw in her case a textbook example of why screening matters. She had no family history of the disease. She had never smoked. She felt fine. "Without low-dose CT screening, detecting tumours at a stage when they can be completely treated is extremely difficult," he said. The imaging had caught something that would have remained invisible until it announced itself through cough, weight loss, or worse.
The hospital's tumour board—thoracic surgeons, medical oncologists, radiologists, specialists in concert—unanimously recommended robot-assisted surgery using the da Vinci Xi system. On June 2, Dr. Trung and his team performed the operation, removing the affected lobe and the surrounding lymph nodes in roughly two hours. The robotic system's magnified 3D vision and articulated instruments allowed them to work with precision in the tight space of the chest, minimizing damage to healthy tissue.
The recovery was swift. One day after surgery, she was walking on her own, eating normally, managing her daily routines. After three nights in the hospital, she went home. The final pathology report confirmed stage IA disease—the earliest meaningful stage—and that the tumour had been completely removed. No chemotherapy. No radiation. Just surgery and follow-up.
Her daughter, Kim Sovannavy, spoke to the weight lifted from the family: "The greatest relief for our family is that my mother did not have to undergo prolonged chemotherapy or radiation treatment. After just one surgery, she was able to return to her normal life." The patient herself was fully recovered at her follow-up visit, looking healthy.
Dr. Trung laid out the stakes plainly. When lung cancer is caught at stage IA, the five-year survival rate reaches 95 per cent. By stage II, it drops to 65 per cent. Stage III sees roughly 30 per cent. Stage IV falls below 15 per cent. Most cases today are diagnosed only after symptoms emerge—persistent cough, weight loss, chest pain—by which point surgery's role shrinks and patients face combinations of chemotherapy, radiotherapy, and immunotherapy that are costlier and less effective.
Low-dose CT screening uses minimal radiation, about one-fifth the dose of a conventional chest CT and roughly half the average annual background radiation exposure. Despite the lower dose, it can detect nodules just millimetres across, far smaller than what a chest X-ray might catch. Many countries now recommend it for people aged 50 and older, including non-smokers and those without obvious risk factors. This woman's case is a quiet argument for why.
Citações Notáveis
Without low-dose CT screening, detecting tumours at a stage when they can be completely treated is extremely difficult.— Dr. Luong Ngoc Trung, robotic thoracic surgeon at FV Hospital
The greatest relief for our family is that my mother did not have to undergo prolonged chemotherapy or radiation treatment. After just one surgery, she was able to return to her normal life.— Kim Sovannavy, the patient's daughter
A Conversa do Hearth Outra perspectiva sobre a história
Why did she choose to add the lung cancer screening to her routine checkup? Was there something that made her think she needed it?
The source doesn't say. She simply chose to include it. Sometimes people add screening tests without a particular reason—just a sense that it's worth checking. That choice, almost casual, is what caught the cancer before it could announce itself.
The nodule doubled in size in three months. That's fast. How alarmed should someone be when they see growth like that?
Fast enough that her daughter decided to cross a border for a second opinion. The doctors recommended watching it initially because seven millimetres is small, but when it became fourteen millimetres, the trajectory changed the calculus. Growth is the signal that something is moving.
The surgery took two hours. Is that considered quick for this kind of procedure?
For a complete lobectomy with lymph node dissection using robotic assistance, yes. The precision of the da Vinci system allows surgeons to work efficiently without the larger incisions that open surgery would require. Smaller wounds mean less tissue trauma, which is why she could walk the next day.
She didn't need chemotherapy afterward. Is that unusual?
It's the outcome you get when you catch it early enough and remove it completely. Stage IA with full surgical resection means the cancer is gone. No microscopic cells hiding elsewhere. That's the whole argument for screening—finding it before it spreads changes what treatment looks like.
What happens now? Is she cured?
She's in follow-up care, which means regular monitoring to catch any recurrence. But yes, the cancer that was there has been removed. She's back to her normal life, which is the point of early detection.